<DOC>
	<DOCNO>NCT02393885</DOCNO>
	<brief_summary>The objective study establish safety effectiveness dual epicardial endocardial ablation procedure patient present Persistent Atrial Fibrillation Longstanding Persistent Atrial Fibrillation</brief_summary>
	<brief_title>Pivotal Study Of A Dual Epicardial &amp; Endocardial Procedure ( DEEP ) Approach</brief_title>
	<detailed_description>The objective study establish safety effectiveness dual epicardial endocardial ablation procedure patient present Persistent Atrial Fibrillation Longstanding Persistent Atrial Fibrillation utilizing AtriCure Bipolar System AtriClipÂ® PRO LAA Exclusion System endoscopic open ablation procedure , follow endocardial mapping ablation procedure utilize commercially available RF base , irrigate , power control , ablation catheter endocardial lesion . The endocardial procedure stag occur 90 day post epicardial surgical procedure .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Symptomatic Persistent Atrial Fibrillation Longstanding Persistent Atrial Fibrillation refractory minimum one Class I Class III AADs . 1 . AF &gt; 10 year . 2 . Refractory hypertension , define systolic ( &gt; 150 mm Hg ) diastolic ( &gt; 90 mm Hg ) blood pressure remain uncontrolled despite sustained therapy 3 . History pulmonary hypertension 4 . Pulmonary vein stenosis one pulmonary vein 5 . EP catheter ablation procedure treat atrial fibrillation within 6 month 6 . Undergone prior cardiothoracic surgery , previous thorax trauma result pneumothorax hemothorax . 7 . Sleep apnea , home oxygen therapy , severe COPD , ( FEV1/FVC &lt; 70 % predict ) patient consider intolerant single lung ventilation . 8 . NYHA Class IV heart failure . 9 . Uncorrected , reversible cause ( ) atrial fibrillation , currently treat arrhythmias atrial fibrillation ( AF ) atrial flutter . 10 . Documented history previous catheter ablation perforation , history pericarditis , pericardial effusion , tamponade . 11 . Structural heart disease require surgical treatment ( i.e . valve disease require repair replacement within 12 month follow surgical ablation procedure ) . 12 . CAD require intervention ( either surgical , i.e . CABG , catheter ) . 13 . Ejection fraction &lt; 30 % 14 . Measured leave atrial diameter &gt; 5.5 cm 15 . Stroke/cerebrovascular accident ( CVA ) within previous six month , carotid artery stenosis great 80 % . 16 . BMI &gt; 35 . 17 . Thrombus leave atrium leave atrial appendage , determine echocardiography ( either baseline TTE ( equivalent diagnostic test ) intraoperative TEE ) . 18 . Blood dyscrasia clot disorder ( i.e . Idiopathic Thrombocytopenic Purpura [ ITP ] Thrombotic Thrombocytopenic Purpura [ TTP ] ) . 19 . Contraindication anticoagulation opinion investigator pose undue risk patient participate endocardial EP procedure . 20 . Documented thromboembolism within previous six month prior sign inform consent . 21 . Has follow atrial myxoma , mural thrombus mural tumor . 22 . A condition congenital anomaly prevents require surgical catheter access . 23 . A comorbid condition , opinion investigator , pose undue risk general anesthesia port access cardiac surgery . 24 . Currently abuse drug alcohol . 25 . Currently participate clinical study last 3 month prior sign inform consent . 26 . A psychological disorder could interfere provision inform consent , completion test , therapy , followup . 27 . A condition , opinion investigator , may jeopardize patient 's wellbeing and/or soundness clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>